# Fish Oil Dry Eye Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/fish-oil-dry-eye-randomized-trial-evidence-review
Category: evidence-review
Summary: Fish Oil Dry Eye Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed
Last reviewed: 2026-06-02
Reviewed by: Migaku Evidence Review
# Fish Oil Dry Eye Randomized Trial: What the Evidence Says

## Quick Answer

Fish Oil Dry Eye Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims | narrative review | 3 | 2026-04-16 | 10.3390/ani16081222 |
| Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review | narrative review | 3 | 2026-04-03 | 10.1007/s40265-025-02241-6 |

## What The Sources Report

- This shift is closely associated with the growing trend of pet humanization, whereby companion animals are increasingly regarded as family members and their diets are expected to support health, longevity, and quality of life in ways analogous to human nutrition. [Vuthisopon Sujira (2026); evidence level 3]
- At the same time, advances in processing technologies, including precision extrusion, encapsulation, and controlled-release systems, have improved the stability and delivery efficiency of functional compounds within complex pet food matrices. [Vuthisopon Sujira (2026); evidence level 3]
- This review provides an update of the current evidence on efficacy, duration of action and safety of existing and emerging treatments. [Cooper Jordan M. (2026); evidence level 3]
- Obstruction typically results from hyperkeratinisation of the glands or lid margin and/or altered meibum composition, which increases meibum viscosity and melting point, and is often associated with anterior blepharitis. [Cooper Jordan M. (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For fish oil dry eye randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Vuthisopon Sujira (2026). Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims. DOI: 10.3390/ani16081222. PMCID: PMC13113406. PMID: 42071988. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13113406/
- Cooper Jordan M. (2026). Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. DOI: 10.1007/s40265-025-02241-6. PMCID: PMC13109184. PMID: 41931217. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This article is licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13109184/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.